Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Photo/Multimedia, Product/Service

Perspectum expands AI and imaging CRO portfolio with Cardiac Imaging


Perspectum, a leading medical imaging company, has begun work on expanding its offering by including cardiac and lung imaging in many new research projects, specifically in Coronavirus multiorgan imaging studies.

Recently launched COVERSCAN and Modify are two such studies, which involve aortic and cardiac imaging using Magnetic Resonance Imaging (MRI) to better understand disease impact and progression of COVID-19 and diabetes, respectively.

Gosia Wamil, Collaborator for the COVERSCAN study and Consultant Cardiologist at Great Western Hospitals NHS Foundation Trust commented: "Recognising the impact of metabolic diseases on the cardiovascular system Perspectum expanded their portfolio with cardiac imaging, allowing full quantification of the cardiac function, volume measurements and tissue characterisation. With the use of T1 mapping sequences and tissue tracking techniques we can probe the heart tissue and recognise early signs of disease. Perspectum are also offering aortic stiffness assessment, which is increasingly used as an indirect predictor of adverse cardiovascular outcomes."

"MRI is a very well-established, robust and safe method to assess cardiovascular risk factors in metabolic syndrome and myocardial function. Extending our unique experience in quantitative abdominal imaging and AI to a multi-organ approach can be a game-changer to smartly aid clinicians and researchers in combining and stratifying a fast-growing number of relevant biomarkers," commented Andrea Borghetto, Head of Imaging Applications, Perspectum. "It is incredible what can be gained in only 30 minutes of minimally invasive magnetic resonance scan when you have the right team at work on it. In addition to that, our ongoing experience and success rate with COVID-19 survivors are enforcing our firm awareness that a product can have the right impact only if applicable and "bullet-proof" in a real clinical scenario."

This latest work in development is part of Perspectum's Atlas program, which is elevating what they can provide for sponsors in cardiometabolic disease. Atlas is a metabolic software suite being developed to improve outcomes for patients by offering a range of measures of organ health. Patients have likened the detail they see about their organ health to an internal mirror.

Quantitative cardiac volume, strain imaging, and aortic stiffness can be directly measured via MRI and are validated biomarkers for use in clinical trials, independently associated with hypertension, chronic kidney disease, cardiovascular events and all-cause mortality. Uniquely, Perspectum can standardise values between scanners and field strengths as well as between modalities, exploiting ultrasound and MR fusion.


These press releases may also interest you

at 02:16
The Primary endpoint was met in the Phase 3 study TWELVE MONTH PERIOD (JUL 2019-JUN 2020) Net revenue SEK 50.5 million (15.6) * EBITDA SEK 29.0 million (-3.0) * Operating profit (EBIT) SEK 26.4 million (-4.2) * Profit after tax SEK 20.0 million...

at 02:10
SDL plc ("SDL" or the "Group"), the intelligent language and content company, today announces its half year results for the six months ended 30 June 2020. Financial Highlights Unaudited Results 1H20 1H19 Change Change at constant...

at 02:05
Technavio has been monitoring the global gear hobbing machines market size and it is poised to grow by USD 82.20 million during 2020-2024, progressing at a CAGR of almost 2% during the forecast period. The report offers an up-to-date analysis...

at 02:05
TransGlobe Energy Corporation ("TransGlobe" or the "Company") is pleased to announce its financial and operating results for the three and six months ended June 30, 2020....

at 01:50
Sasol will announce group financial results for the year ended 30 June 2020 (2020 financial year) that were impacted by the COVID-19 pandemic and a severe decline in crude oil and chemical product prices. The impact of the weak macro-economic...

at 01:05
Technavio has been monitoring the global automotive carbon monocoque chassis market size and it is poised to grow by 3.15 thousand units during 2020-2024, progressing at a CAGR of almost 2% during the forecast period. The report offers an up-to-date...



News published on 16 july 2020 at 09:10 and distributed by: